{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:09:37Z","timestamp":1791317377869,"version":"4.3.1"},"reference-count":110,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Hepatocellular carcinoma (HCC) develops predominantly from chronic liver injury, with diet representing a clinically actionable yet mechanistically complex modulator of hepatic carcinogenesis. Despite advances in immunotherapy, long-term survival remains poor, underscoring the need for complementary preventive and adjunctive strategies. Methods: We conducted a narrative review of epidemiological, experimental, and clinical literature on dietary patterns, polyphenols, and non-polyphenol nutraceuticals for HCC prevention and management, with a focus on underlying molecular and cellular mechanisms. Results: Dietary polyphenols and selected nutraceuticals exert pleiotropic effects on signaling pathways implicated in HCC, including NF-\u03baB, STAT3, TGF-\u03b2\/SMAD, PI3K\/AKT, and Wnt\/\u03b2-catenin, while modulating hepatic stellate cell activation, immune cell polarization, and microbiome-derived metabolites. Preclinical studies suggest that some compounds may enhance antitumor immunity and sensitize tumors to systemic therapies; however, clinical translation is constrained by limited bioavailability, pharmacokinetic variability, formulation heterogeneity, and a lack of high-quality trials. Conclusions: This review highlights the potential of dietary patterns and nutraceuticals in HCC prevention and as adjunctive therapies. It outlines key translational priorities, including etiologic stratification, biomarker-driven trial design, and rigorous safety evaluation.<\/jats:p>","DOI":"10.3390\/nu18111783","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:19:42Z","timestamp":1780316382000},"page":"1783","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dietary Polyphenols and Selected Nutraceuticals in Hepatocellular Carcinoma: Mechanistic Insights, Translational Evidence, and Clinical Prospects"],"prefix":"10.3390","volume":"18","author":[{"given":"Fareeha","family":"Arshad","sequence":"first","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshiya","family":"Akbar","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2288-4287","authenticated-orcid":false,"given":"Raja","family":"Chinnappan","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Imran","family":"Khan","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"},{"name":"King Faisal Specialist Hospital and Research Center, Jeddah 23433, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-910X","authenticated-orcid":false,"given":"Ahmed","family":"Yaqinuddin","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itika","family":"Arora","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Adams, A.M., Kaseb, A.O., and Tran Cao, H.S. (2025). Hepatocellular carcinoma. Transplant Oncology: A Frontier in Multidisciplinary Cancer Care, Academic Press.","DOI":"10.1016\/B978-0-443-21901-6.00003-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11864-023-01098-9","article-title":"Hepatocellular Carcinoma: A Narrative Review on Current Knowledge and Future Prospects","volume":"24","author":"Alawyia","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17998\/jlc.2024.03.13","article-title":"Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide","volume":"24","author":"Kim","year":"2024","journal-title":"J. Liver Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajcnut.2024.05.018","article-title":"Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: A prospective cohort study","volume":"120","author":"Lind","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e013739","DOI":"10.1136\/bmjopen-2016-013739","article-title":"Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: A systematic review and dose-response meta-Analysis","volume":"7","author":"Kennedy","year":"2017","journal-title":"BMJ Open"},{"key":"ref_8","first-page":"4369","article-title":"Coffee consumption and risk of hepatocellular carcinoma: A meta-analysis of eleven epidemiological studies","volume":"2016","author":"Bai","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8394818","DOI":"10.1155\/2018\/8394818","article-title":"The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases","volume":"2018","author":"Li","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12032-024-02353-1","article-title":"Liver cancer wars: Plant-derived polyphenols strike back","volume":"41","author":"Niu","year":"2024","journal-title":"Med. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ptr.8043","article-title":"Human diet-derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization","volume":"38","author":"Hu","year":"2024","journal-title":"Phyther. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kiruthiga, C., Devi, K.P., Nabavi, S.M., and Bishayee, A. (2020). Autophagy: A potential therapeutic target of polyphenols in hepatocellular carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12030562"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e70011","DOI":"10.1002\/mnfr.70011","article-title":"Polyphenols: Potential Applications in Cancer Therapy","volume":"69","author":"Estrela","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112575","DOI":"10.1016\/j.isci.2025.112575","article-title":"A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability","volume":"28","author":"Kroon","year":"2025","journal-title":"iScience"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.phymed.2015.10.018","article-title":"Polyphenol-based nutraceuticals for the prevention and treatment of cardiovascular disease: Review of human evidence","volume":"23","author":"Visioli","year":"2016","journal-title":"Phytomedicine"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Saad, A.M., Mohammed, D.M., Alkafaas, S.S., Ghosh, S., Negm, S.H., Salem, H.M., Fahmy, M.A., Semary, H.E., Ibrahim, E.H., and AbuQamar, S.F. (2025). Dietary polyphenols and human health: Sources, biological activities, nutritional and immunological aspects, and bioavailability\u2014A comprehensive review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1653378"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Czauderna, C., Castven, D., Mahn, F.L., and Marquardt, J.U. (2019). Context-dependent role of NF-\u03baB signaling in primary liver cancer\u2014From tumor development to therapeutic implications. Cancers, 11.","DOI":"10.3390\/cancers11081053"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.fct.2012.04.002","article-title":"Chemoprevention of liver cancer by plant polyphenols","volume":"50","author":"Stagos","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e13346","DOI":"10.1111\/cpr.13346","article-title":"Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention","volume":"56","author":"Li","year":"2023","journal-title":"Cell Prolif."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ahmed, Z.S.O., Khan, E., Elias, N., Elshebiny, A., and Dou, Q. (2025). Updated Review on Natural Polyphenols: Molecular Mechanisms, Biological Effects, and Clinical Applications for Cancer Management. Biomolecules, 15.","DOI":"10.3390\/biom15050629"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105705","DOI":"10.1016\/j.jff.2023.105705","article-title":"Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy","volume":"108","author":"Meybodi","year":"2023","journal-title":"J. Funct. Foods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","article-title":"Curcumin, a component of golden spice: From bedside to bench and back","volume":"32","author":"Prasad","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3892\/or.2013.2310","article-title":"Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells","volume":"29","author":"Du","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100233","DOI":"10.1016\/j.prmcm.2023.100233","article-title":"Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action","volume":"6","author":"Bhattacharya","year":"2023","journal-title":"Pharmacol. Res.\u2014Mod. Chin. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.18632\/aging.103338","article-title":"Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN\/AKT signaling","volume":"12","author":"Dai","year":"2020","journal-title":"Aging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e70555","DOI":"10.1002\/fsn3.70555","article-title":"The Beneficial Effects of Resveratrol on Hepatocellular Carcinoma and Nonalcoholic Fatty Liver Disease: Modulation of Apoptosis, Autophagy, Inflammation, and Oxidative Stress","volume":"13","author":"Wan","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sethi, G., Rath, P., Chauhan, A., Ranjan, A., Choudhary, R., Ramniwas, S., Sak, K., Aggarwal, D., Rani, I., and Tuli, H.S. (2023). Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020712"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1002\/cam4.2388","article-title":"Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2\/STAT3 signaling pathway","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/ijo.2015.3053","article-title":"Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas\/Fas-ligand besides the TGF-\u03b2 pathway","volume":"47","author":"Yee","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108612","DOI":"10.1016\/j.biopha.2019.108612","article-title":"Luteolin, a flavonoid, as an anticancer agent: A review","volume":"112","author":"Imran","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_31","first-page":"732516","article-title":"Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells","volume":"2014","author":"Wang","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116862","DOI":"10.1016\/j.biopha.2024.116862","article-title":"The most recent progress of baicalein in its anti-neoplastic effects and mechanisms","volume":"176","author":"Lei","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e27533","DOI":"10.1016\/j.heliyon.2024.e27533","article-title":"Flavonoids: A treasure house of prospective pharmacological potentials","volume":"10","author":"Hasnat","year":"2024","journal-title":"Heliyon"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Elwan, A.G., Mohamed, T.M., Beltagy, D.M., and El Gamal, D.M. (2025). The therapeutic role of naringenin nanoparticles on hepatocellular carcinoma. BMC Pharmacol. Toxicol., 26.","DOI":"10.1186\/s40360-024-00823-w"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105502","DOI":"10.1016\/j.jff.2023.105502","article-title":"Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid","volume":"104","author":"Koushki","year":"2023","journal-title":"J. Funct. Foods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2515690X211068826","DOI":"10.1177\/2515690X211068826","article-title":"Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions","volume":"27","author":"Koltai","year":"2022","journal-title":"J. Evid.-Based Integr. Med."},{"key":"ref_37","first-page":"885","article-title":"Silymarin-mediated regulation of the cell cycle and DNA damage response exerts antitumor activity in human hepatocellular carcinoma","volume":"15","author":"Cui","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yu, M.H., Tsai, M.C., Wang, C.C., Wu, S.W., Chang, Y.J., Wu, C.H., and Wang, C.J. (2021). Mulberry Leaf Polyphenol Extract and Rutin Induces Autophagy Regulated by p53 in Human Hepatoma HepG2 Cells. Pharmaceuticals, 14.","DOI":"10.3390\/ph14121310"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1021\/jf100718b","article-title":"Polyphenol-rich extracts from solanum nigrum attenuated PKC \u03b1-mediated migration and invasion of hepatocellular carcinoma cells","volume":"58","author":"Yang","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"De Stefanis, D., Scim\u00e8, S., Accomazzo, S., Catti, A., Occhipinti, A., Bertea, C.M., and Costelli, P. (2019). Anti-proliferative effects of an extra-virgin olive oil extract enriched in ligstroside aglycone and oleocanthal on human liver cancer cell lines. Cancers, 11.","DOI":"10.3390\/cancers11111640"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fct.2008.12.024","article-title":"Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells","volume":"47","author":"Chen","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12010-013-0561-z","article-title":"Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells","volume":"172","author":"Zhao","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/1940-6207.CAPR-19-0383","article-title":"Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma","volume":"13","author":"Sojoodi","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/bph.16232","article-title":"Natural products targeting tumour angiogenesis","volume":"182","author":"Lu","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.29219\/fnr.v65.3602","article-title":"Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA\/AMPK\/eEF2K pathway","volume":"65","author":"Gao","year":"2021","journal-title":"Food Nutr. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbrc.2015.10.031","article-title":"A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma","volume":"468","author":"Hu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Elnawasany, S., Haggag, Y.A., Shalaby, S.M., Soliman, N.A., EL Saadany, A.A., Ibrahim, M.A.A., and Badria, F. (2023). Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line. BMC Complement. Med. Ther., 23.","DOI":"10.1186\/s12906-023-04096-4"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chimento, A., De Luca, A., D\u2019Amico, M., De Amicis, F., and Pezzi, V. (2023). The Involvement of Natural Polyphenols in Molecular Mechanisms Inducing Apoptosis in Tumor Cells: A Promising Adjuvant in Cancer Therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021680"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Li, D., Cao, D., Cui, Y., Sun, Y., Jiang, J., and Cao, X. (2023). The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1201085"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00432-024-05878-0","article-title":"Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4","volume":"150","author":"Jiang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"117769","DOI":"10.1016\/j.biopha.2024.117769","article-title":"Ferroptosis in hepatocellular carcinoma: Mechanisms and therapeutic implications","volume":"182","author":"Tu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e32288","DOI":"10.1016\/j.heliyon.2024.e32288","article-title":"Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1\u03b1 signalling axis in liver cancer","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lee, C.H., Fu, Y., Yang, S.J., and Chi, C.C. (2020). Effects of Omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: A systematic review and meta-analysis. Nutrients, 12.","DOI":"10.3390\/nu12092769"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.clnu.2025.05.013","article-title":"Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: A meta-analysis of randomized controlled trials","volume":"50","author":"Kim","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1158\/1535-7163.MCT-09-0551","article-title":"Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking \u03b2-catenin and cyclooxygenase-2","volume":"8","author":"Lim","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Jiang, W., Li, F.R., Yang, H.H., Chen, G.C., and Hua, Y.F. (2021). Relationship Between Fish Oil Use and Incidence of Primary Liver Cancer: Findings From a Population-Based Prospective Cohort Study. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.771984"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1038\/s41467-024-47960-8","article-title":"Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.7555\/JBR.26.20120058","article-title":"Omega-3 fatty acid improves the clinical outcome of hepatectomized patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma","volume":"26","author":"Wu","year":"2012","journal-title":"J. Biomed. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000509979","article-title":"Clinical Efficacy of Perioperative Immunonutrition Containing Omega-3-Fatty Acids in Patients Undergoing Hepatectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"76","author":"Gao","year":"2020","journal-title":"Ann. Nutr. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e032390","DOI":"10.1161\/JAHA.123.032390","article-title":"Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"13","author":"Javaid","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.30368","article-title":"Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients with Nonalcoholic Steatohepatitis and Advanced Fibrosis","volume":"71","author":"Vuppalanchi","year":"2020","journal-title":"Hepatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: The selenium and vitamin E cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"c5702","DOI":"10.1136\/bmj.c5702","article-title":"Effects of vitamin E on stroke subtypes: Meta-analysis of randomised controlled trials","volume":"341","author":"Glynn","year":"2010","journal-title":"BMJ"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.livres.2017.11.005","article-title":"Gut microbiota, fatty liver disease, and hepatocellular carcinoma","volume":"2","author":"Chu","year":"2018","journal-title":"Liver Res."},{"key":"ref_68","first-page":"E1306","article-title":"Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Yang, X., Lei, L., Shi, W., Li, X., Huang, X., Lan, L., Lin, J., Liang, Q., Li, W., and Yang, J. (2024). Probiotics are beneficial for liver cirrhosis: A systematic review and meta-analysis of randomized control trials. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1379333"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Shi, K., Zhang, Q., Zhang, Y., Bi, Y., Zeng, X., and Wang, X. (2023). Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.1104399"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"114314","DOI":"10.1016\/j.fct.2023.114314","article-title":"Lactobacillus rhamnosus probiotic treatment modulates gut and liver inflammatory pathways in a hepatocellular carcinoma murine model. A preliminary study","volume":"183","author":"Nenu","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"ref_72","first-page":"4500","article-title":"Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt\/\u03b2-catenin pathway","volume":"22","author":"Chang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1568009623666230418121130","article-title":"The Role of Oxidative Stress in the Development and Therapeutic Intervention of Hepatocellular Carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4234061","DOI":"10.1155\/2016\/4234061","article-title":"Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Zhou, J., Zheng, Q., and Chen, Z. (2022). The Nrf2 Pathway in Liver Diseases. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.826204"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ramos-Tovar, E., and Muriel, P. (2020). Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants, 9.","DOI":"10.3390\/antiox9121279"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sas, Z., Cendrowicz, E., Weinh\u00e4user, I., and Rygiel, T.P. (2022). Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073778"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Xu, J., Lin, H., Wu, G., Zhu, M., and Li, M. (2021). IL-6\/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.760971"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Lee, C., and Cheung, S.T. (2019). STAT3: An emerging therapeutic target for hepatocellular carcinoma. Cancers, 11.","DOI":"10.3390\/cancers11111646"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., and Li, Y. (2021). Macrophage Polarization and Its Role in Liver Disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.803037"},{"key":"ref_83","first-page":"20230394","article-title":"Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma","volume":"21","author":"Song","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep4.1905","article-title":"Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma","volume":"6","author":"Ponziani","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e008686","DOI":"10.1136\/jitc-2023-008686","article-title":"Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_87","first-page":"077","article-title":"Role of Lipogenesis Rewiring in Hepatocellular Carcinoma","volume":"42","author":"Zhou","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: Therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_89","first-page":"103","article-title":"Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males with Metabolic Abnormalities","volume":"72","author":"Parks","year":"2019","journal-title":"Hepatology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","article-title":"High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate","volume":"35","author":"Zhou","year":"2023","journal-title":"Cell Metab."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sun, B., Liu, X., Jiang, Y., Qi, S.Y., Guan, Z., and Li, H. (2025). Proteomics reveals periodontitis-driven oxidative stress and lipid metabolism disruption in NAFLD. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1600015"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_94","first-page":"EVIDoa2100070","article-title":"Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma","volume":"1","author":"Lau","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): A randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4254\/wjh.v13.i9.1019","article-title":"Herbal and dietary supplement induced liver injury: Highlights from the recent literature","volume":"13","author":"Woo","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/livers4010008","article-title":"Herbal- and Dietary-Supplement-Induced Liver Injury: A Review of the Recent Literature","volume":"4","author":"Cundra","year":"2024","journal-title":"Livers"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"115170","DOI":"10.1016\/j.biopha.2023.115170","article-title":"The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)","volume":"165","author":"Farghadani","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41419-024-06641-6","article-title":"Dietary factors and their influence on immunotherapy strategies in oncology: A comprehensive review","volume":"15","author":"Golonko","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Guven, D.C., Sahin, T.K., Rizzo, A., Ricci, A.D., Aksoy, S., and Sahin, K. (2022). The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges. Appl. Sci., 12.","DOI":"10.3390\/app122010548"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1002\/jcb.28877","article-title":"Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial","volume":"120","author":"Panahi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis","volume":"15","author":"Mahadeva","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00268-021-06388-7","article-title":"Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial","volume":"46","author":"Roussel","year":"2022","journal-title":"World J. Surg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","article-title":"Liver Injury Associated with Turmeric\u2014A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]","volume":"136","author":"Navarro","year":"2023","journal-title":"Am. J. Med."},{"key":"ref_106","first-page":"e05239","article-title":"Scientific opinion on the safety of green tea catechins","volume":"16","author":"Younes","year":"2018","journal-title":"EFSA J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/DDDT.S180079","article-title":"Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: Experimental findings and translational perspectives","volume":"2019","author":"Bimonte","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Chen, P., Yang, C., Ren, K., Xu, M., Pan, C., Ye, X., and Li, L. (2024). Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1504948"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"He, X.X., Wu, X.L., Chen, R.P., Chen, C., Liu, X.G., Wu, B.J., and Huang, Z.M. (2016). Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162368"},{"key":"ref_110","first-page":"e68002","article-title":"Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"16","author":"Aziz","year":"2024","journal-title":"Cureus"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1783\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:35:16Z","timestamp":1780317316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":110,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["nu18111783"],"URL":"https:\/\/doi.org\/10.3390\/nu18111783","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}